317690.Kq
317690.KQ is a South Korean company operating in the healthcare services and equipment industry, primarily generating revenue through the development, production, and distribution of medical equipment and supplies.
Business. 317690.KQ is a South Korean company operating in the healthcare services and equipment industry, primarily generating revenue through the development, production, and distribution of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
317690.KQ is a South Korean company operating in the healthcare services and equipment industry, primarily generating revenue through the development, production, and distribution of medical equipment and supplies.
The company's capital structure is characterized by a low debt-to-equity ratio of 0.24, indicating a conservative leverage profile. It holds a substantial amount of cash and equivalents, amounting to KRW 38.5 billion, which is significantly higher than its total liabilities of KRW 12.7 billion, resulting in a strong current ratio of 4.27. This liquidity position suggests the company has the capacity to meet short-term obligations without immediate pressure.
Profitability metrics, however, are negative. The company reported a net loss of KRW 19.5 billion and an operating loss of KRW 16.5 billion in the latest period. Return on equity (ROE) and return on assets (ROA) are -48.64% and -36.95%, respectively, which are well below the typical performance of the industry. These figures indicate a significant underperformance relative to industry norms and suggest operational inefficiencies or market challenges.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segmental or geographic diversification increases the company's exposure to sector-specific risks and potential market volatility.
Looking ahead, the company's growth trajectory is uncertain. The latest financial data does not provide forward-looking guidance, and there are no disclosed plans for revenue expansion or market penetration. The absence of a clear growth strategy, combined with current financial losses, raises concerns about the company's ability to achieve sustainable growth in the near term.
Risk factors include the company's negative operating and net income, which could lead to liquidity constraints if the trend continues. However, the company's strong cash reserves and low debt levels mitigate immediate liquidity risk. There is no evidence of dilution pressure in the near term, as both basic and diluted shares outstanding are identical, and no recent equity issuance or dilutive events are reported.
Recent events, as disclosed in the latest financial filing, include a significant operating and net loss, which may signal underlying operational or market challenges. No recent regulatory actions, product launches, or strategic partnerships are reported in the available data, suggesting a lack of recent positive developments that could drive future performance.
- The company has a strong liquidity position with a current ratio of 4.27 and significant cash reserves.
- It is currently unprofitable, with a net loss of KRW 19.5 billion and a return on equity of -48.64%.
- The company's business is not diversified across segments or geographies, increasing its exposure to sector-specific risks.
- There is no immediate dilution risk, but the company's financial performance raises concerns about long-term sustainability.
- The company lacks a clear growth strategy and has not disclosed any recent positive developments.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 317690.KQ Market data — financials · 2026-05-26